Trial Profile
Sumatriptan non-responders: evaluation of a possible biomarker
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2016
Price :
$35
*
At a glance
- Drugs Sumatriptan (Primary)
- Indications Migraine
- Focus Biomarker; Therapeutic Use
- Acronyms SNEB
- 01 Oct 2013 New source identified and integrated (Netherlands Trial Register: NTR4171).
- 07 Dec 2012 New trial record